Silver D, Puckett C L
Surgery. 1976 Dec;80(6):748-55.
Sixteen patients with refractory primary and secondary lymphedema have had multifilament Teflon wick lymphangioplasties during the past 10 years. There were no operative deaths or operative complications. All patients experienced an early reduction of their edema, with objective improvement lasting 6 months to 5 years. The average duration of benefit was 13 months. Subjective improvement has lasted to 7 years. Lymphangioplasty is simple, virtually free of complications, and offers periods of control of edema and cellulitis that compare favorably with those obtained by other operative procedures. It should be considered for the management of patients with incapacitating lymphedema, especially those patients with a limited life expectancy.
在过去10年中，16例原发性和继发性难治性淋巴水肿患者接受了多丝聚四氟乙烯芯淋巴管成形术。无手术死亡或手术并发症。所有患者的水肿均早期减轻，客观改善持续6个月至5年。获益的平均持续时间为13个月。主观改善持续至7年。淋巴管成形术操作简单，几乎无并发症，且控制水肿和蜂窝织炎的时间与其他手术方法相比效果良好。对于失能性淋巴水肿患者，尤其是预期寿命有限的患者，应考虑采用该方法进行治疗。
